TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8609337

Group type: EXPERIMENTAL
Intervention: Dobutamine-atropine stress echocardiography
Number of subjects: 360

Group type: COMPARATOR
Intervention: Dipyridamole-atropine stress echocardiography
Number of subjects: 360
Study: 2019161

Group type: EXPERIMENTAL
Intervention: Metaproterenol (5 percent solution, 0.3 ml) plus atropine sulfate (2.5 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Metaproterenol (5 percent solution, 0.3 ml) alone
Number of subjects: 40
Study: 400931

Group type: EXPERIMENTAL
Intervention: Cefoxitin
Number of subjects: 596

Group type: COMPARATOR
Intervention: Cephalothin
Number of subjects: 596
Study: 31092617

Group type: EXPERIMENTAL
Intervention: Biosimilar ABP 215
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 0
Study: 28758951

Group type: EXPERIMENTAL
Intervention: Iron supplementation (Fe condition) - 12 mg of iron twice daily (24 mg/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (Control condition; CON) - no iron supplementation
Number of subjects: 14
Study: 26040352

Group type: EXPERIMENTAL
Intervention: Weight loss program (22 weeks, 3 times/week training, hypocaloric diet 25-30% less energy intake)
Number of subjects: 180
Study: 23880084

Group type: EXPERIMENTAL
Intervention: Low tidal volume ventilation (6 mL/kg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: High tidal volume ventilation (12 mL/kg)
Number of subjects: 16
Study: 21269646

Group type: EXPERIMENTAL
Intervention: landiolol hydrochloride
Number of subjects: 140

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 140
Study: 18496750

Group type: EXPERIMENTAL
Intervention: Erlotinib (150 mg orally daily)
Number of subjects: 69
Study: 17711594

Group type: EXPERIMENTAL
Intervention: Unilateral lobar placement of endobronchial valves plus optimal medical management
Number of subjects: 270

Group type: COMPARATOR
Intervention: Optimal medical management alone
Number of subjects: 270
Study: 15482074

Group type: EXPERIMENTAL
Intervention: Population of linear experts model (POLE)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 3
Study: 11468032

Group type: EXPERIMENTAL
Intervention: Etifoxine 50 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Etifoxine 100 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Lorazepam 2 mg
Number of subjects: 48
Study: 9763356

Group type: EXPERIMENTAL
Intervention: Vitamins (specific type and dosage not mentioned)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7845693

Group type: EXPERIMENTAL
Intervention: Experimental lenses (dyed to provide appropriate chromaticity)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control lenses (similar colour but with chromaticity outside the range of improvement)
Number of subjects: 68
Study: 3398242

Group type: EXPERIMENTAL
Intervention: DDD pacing mode
Number of subjects: 18

Group type: COMPARATOR
Intervention: VVI pacing mode
Number of subjects: 18
Study: 30346346

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA injection
Number of subjects: 120
Study: 28376756

Group type: EXPERIMENTAL
Intervention: Ultrasound guided needling and lavage (barbotage) with subacromial steroid injection
Number of subjects: 210

Group type: COMPARATOR
Intervention: Sham barbotage with subacromial steroid injection
Number of subjects: 210

Group type: COMPARATOR
Intervention: Sham barbotage without subacromial steroid injection (placebo group)
Number of subjects: 210
Study: 26118515

Group type: EXPERIMENTAL
Intervention: Remote after‐effects of resistive static contraction of the pelvic depressors (RSCPD)
Number of subjects: 10

Group type: COMPARATOR
Intervention: After‐effects of static contraction of upper extremity muscles (SCUE)
Number of subjects: 10
Study: 23299003

Group type: EXPERIMENTAL
Intervention: School-based internet obesity prevention program with coping skills training
Number of subjects: 384

Group type: COMPARATOR
Intervention: School-based internet obesity prevention program without coping skills training
Number of subjects: 384
Study: 21450115

Group type: EXPERIMENTAL
Intervention: dairy-Se (150 μg/d)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: yeast-Se (150 μg/d)
Number of subjects: 23
Study: 19083557

Group type: COMPARATOR
Intervention: Body contouring surgery in the ideal weight group
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Body contouring surgery in the severely morbidly obese group
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Body contouring surgery in the obese group
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Body contouring surgery in the morbidly obese group
Number of subjects: 129
Study: 17926615

Group type: EXPERIMENTAL
Intervention: Abdominal acupuncture at Zhongwan (CV 12), Guanyuan (CV 4) and others
Number of subjects: 62

Group type: COMPARATOR
Intervention: Traditional acupuncture at Fengchi (GB 20) and cervical Jiaji (EX-B 2)
Number of subjects: 62
Study: 15483410

Group type: EXPERIMENTAL
Intervention: Aselizumab 0.5 mg/kg
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Aselizumab 1 mg/kg
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Aselizumab 2 mg/kg
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Aselizumab (all dosages)
Number of subjects: 84
Study: 11529339

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.3 mg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.9 mg/kg
Number of subjects: 60
Study: 9773794

Group type: EXPERIMENTAL
Intervention: Phenolphthalein alone
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Resin plus Phenolphthalein
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sorbitol plus Resin
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Resin regimens (various)
Number of subjects: 6
Study: 7835118

Group type: EXPERIMENTAL
Intervention: Low dosage growth hormone (GH) co-administered with gonadotropin (Gn)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 3293642

Group type: EXPERIMENTAL
Intervention: Adrenaline 0.2 ml (0.2 mg) with 5% lignocaine 2 ml in 7.5% dextrose
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Adrenaline 0.4 ml with 5% lignocaine 2 ml in 7.5% dextrose
Number of subjects: 60

Group type: COMPARATOR
Intervention: 5% lignocaine 2 ml in 7.5% dextrose with physiological saline 1 ml
Number of subjects: 60
Study: 31838113

Group type: EXPERIMENTAL
Intervention: Oxygen therapy at 6 l/min for 6 to 12 hours
Number of subjects: 5010

Group type: COMPARATOR
Intervention: Ambient air
Number of subjects: 5010

Group type: EXPERIMENTAL
Intervention: Oxygen therapy
Number of subjects: 5010
Study: 30384961

Group type: EXPERIMENTAL
Intervention: Emotion dysregulation
Number of subjects: 188
Study: 28382673

Group type: EXPERIMENTAL
Intervention: X:IT intervention (medium implementation)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: X:IT intervention (high implementation)
Number of subjects: 49
Study: 26033271

Group type: EXPERIMENTAL
Intervention: Functional Training Group (FTG)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 29
Study: 23801029

Group type: EXPERIMENTAL
Intervention: Balloon osteoplasty
Number of subjects: 24

Group type: COMPARATOR
Intervention: Traditional methods of fracture reduction
Number of subjects: 24
Study: 22858814

Group type: EXPERIMENTAL
Intervention: Alcohol-based handrubs (ABH)
Number of subjects: 1727

Group type: COMPARATOR
Intervention: Existing handwashing practices (control)
Number of subjects: 1727
Study: 19950305

Group type: EXPERIMENTAL
Intervention: Multidisciplinary treatment for fibromyalgia
Number of subjects: 0
Study: 17242147

Group type: EXPERIMENTAL
Intervention: Apricitabine at 600 mg twice daily
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Apricitabine at 600 mg twice daily with lamivudine at 300 mg once daily
Number of subjects: 21

Group type: COMPARATOR
Intervention: Lamivudine at 300 mg once daily
Number of subjects: 21
Study: 15735187

Group type: EXPERIMENTAL
Intervention: iTCC (removable cast walker rendered irremovable)
Number of subjects: 41

Group type: COMPARATOR
Intervention: TCC (total contact cast)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: iTCC
Number of subjects: 41

Group type: COMPARATOR
Intervention: TCC
Number of subjects: 41
Study: 11987981

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9821566

Group type: EXPERIMENTAL
Intervention: Extensive information
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control manipulation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Baseline partial pressure of CO2
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Anxiety sensitivity
Number of subjects: 50
Study: 8009342

Group type: EXPERIMENTAL
Intervention: Intrathecal oxytocin (ED50 0.172 micrograms/kg in chronic pain, 0.121 micrograms/kg in acute pain)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intrathecal oxytocin (ED50 0.067 micrograms/kg in rats)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High levels of oxytocin (ED50 17.915 micrograms/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High levels of oxytocin (LD50 27.224 micrograms/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxytocin antagonist [d(CH2)5, Tyr(Me)2, Orn8]-vasotocin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Opiate receptor-blocker naloxone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxytocin antagonist
Number of subjects: 0
Study: 2691131

Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 30722727

Group type: EXPERIMENTAL
Intervention: BMI training with voluntary desynchronization of ipsilesional EEG-sensorimotor rhythms triggering paretic upper-limb movements via robotic orthoses (experimental group, n = 16)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Physiotherapy following BMI sessions and home-based training program (both groups)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Random orthoses movements (sham group, n = 12)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: fMRI-BOLD laterality index assessment (both groups)
Number of subjects: 28
Study: 28059417

Group type: EXPERIMENTAL
Intervention: 22 g freeze‐dried highbush blueberry powder per day
Number of subjects: 40

Group type: COMPARATOR
Intervention: 22 g placebo powder per day
Number of subjects: 40
Study: 26229036

Group type: EXPERIMENTAL
Intervention: ROMICAT score derived from semi-automated quantitative measurements of high-risk plaque features
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Model including ROMICAT score, gender, and >50% stenosis
Number of subjects: 260

Group type: COMPARATOR
Intervention: Model including only gender and >50% stenosis
Number of subjects: 260
Study: 24469140

Group type: EXPERIMENTAL
Intervention: Tacrolimus mouth rinse
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dexamethasone (Control)
Number of subjects: 0
Study: 20839040

Group type: EXPERIMENTAL
Intervention: Weighted vests
Number of subjects: 6
Study: 19039454

Group type: EXPERIMENTAL
Intervention: Topical latanoprost (n=10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lubricant drop (control group, n=10)
Number of subjects: 20
Study: 16982402

Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 14600698

Group type: EXPERIMENTAL
Intervention: Quantec‐E irrigation pump with 12 mL of 5.25% NaOCl, followed by 6 mL EDTA 17%, and a final flush with 4 mL 5.25% NaOCl
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional needle and syringe irrigation with the same volumes of NaOCl and EDTA
Number of subjects: 40

Group type: COMPARATOR
Intervention: Negative control (5 teeth sectioned without instrumentation)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Positive control (5 teeth instrumented dry without irrigation)
Number of subjects: 40
Study: 10916106

Group type: EXPERIMENTAL
Intervention: High-flux dialyzers with 175 micro inner diameter polysulfone fibers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard 200 micro polysulfone hollow fiber dialyzers
Number of subjects: 0
Study: 8729158

Group type: EXPERIMENTAL
Intervention: Dermagraft (one piece applied weekly for 8 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional wound closure methods (Control)
Number of subjects: 50
Study: 1574839

Group type: EXPERIMENTAL
Intervention: Jittered stimulus with sawtooth waveform and contrast reversal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Polarity-specific VEPs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Polarity VEPs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard VEPs
Number of subjects: 0
Study: 3929318

Group type: EXPERIMENTAL
Intervention: 1-alpha-acetylmethadol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 0
Study: 29574995

Group type: EXPERIMENTAL
Intervention: Peer support with usual education
Number of subjects: 400

Group type: COMPARATOR
Intervention: Usual education
Number of subjects: 400
Study: 27779937

Group type: EXPERIMENTAL
Intervention: Parents as Teachers Enhanced intervention
Number of subjects: 82

Group type: COMPARATOR
Intervention: Parents as Teachers (control) curriculum
Number of subjects: 82
Study: 24924703

Group type: EXPERIMENTAL
Intervention: Supervised, progressive resistance and functional group training for 3 months (2 times per week for two hours)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Low-intensity motor placebo activity program
Number of subjects: 61
Study: 22835632

Group type: EXPERIMENTAL
Intervention: Single endometrial biopsy regimen (S-EBR)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Hysteroscopy without endometrial scraping
Number of subjects: 200
Study: 20237063

Group type: EXPERIMENTAL
Intervention: Zinc treatment (20 mg/d for 10 days)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Zinc treatment plus supplementation (10 mg/d for 3 months after initial treatment)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Zinc treatment (ZT)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Zinc treatment plus supplementation (ZT+S)
Number of subjects: 148
Study: 18537187

Group type: EXPERIMENTAL
Intervention: G-CSF (10 microg/kg/day for 5 days)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 24
Study: 15893176

Group type: EXPERIMENTAL
Intervention: Haplotype 3 encompassing the E670G variant
Number of subjects: 691

Group type: EXPERIMENTAL
Intervention: E670G variant
Number of subjects: 691

Group type: COMPARATOR
Intervention: E670G genotypes
Number of subjects: 691

Group type: COMPARATOR
Intervention: Global haplotype distribution
Number of subjects: 691
Study: 14602842

Group type: EXPERIMENTAL
Intervention: Caregiver age
Number of subjects: 327
Study: 10971545

Group type: EXPERIMENTAL
Intervention: Cystic fibrosis patients (n=43)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Cystic fibrosis patients with DeltaF508 genotype (n=33)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Cystic fibrosis patients with other CF genotypes (n=10)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Healthy volunteer control subjects
Number of subjects: 43
Study: 8803648

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1451291

Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide gel 5%
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Topical isotretinoin 0.05%
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo (vehicle base)
Number of subjects: 77
Study: 6548348

Group type: EXPERIMENTAL
Intervention: Perphenazine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prochlorperazine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other anti-emetic drugs
Number of subjects: 0
Study: 29843553

Group type: EXPERIMENTAL
Intervention: Ferrous bis-glycinate tablets once daily for eight consecutive weeks
Number of subjects: 187

Group type: COMPARATOR
Intervention: Ferrous glycine sulfate capsules once daily for eight consecutive weeks
Number of subjects: 187
Study: 29436624

Group type: EXPERIMENTAL
Intervention: Lou type equation for warfarin dosing
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (doctor's recommendations)
Number of subjects: 87
Study: 27412465

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 148

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 148
Study: 25179592

Group type: EXPERIMENTAL
Intervention: Biventricular (BiV) pacing
Number of subjects: 177

Group type: COMPARATOR
Intervention: Right ventricular apical (RVA) pacing
Number of subjects: 177
Study: 22889573

Group type: EXPERIMENTAL
Intervention: Exercise intervention (6-month supervised program, 3 times a week)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Sedentary control
Number of subjects: 140
Study: 20179126

Group type: EXPERIMENTAL
Intervention: Multi-component physical activity programme (n=297) including structured physical education lessons, additional lessons, daily activity breaks, and homework.
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Multi-component physical activity programme (n=297)
Number of subjects: 540

Group type: COMPARATOR
Intervention: Control group (n=205)
Number of subjects: 540
Study: 18048554

Group type: EXPERIMENTAL
Intervention: Client-centered care approach
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Context-sensitive, context-informed dialog
Number of subjects: 25
Study: 16351361

Group type: EXPERIMENTAL
Intervention: Response compatibility processes (e.g., Implicit Association Test, affective priming with an evaluative decision task)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stimulus compatibility processes (e.g., semantic priming with a lexical-decision task)
Number of subjects: 0
Study: 12160197

Group type: EXPERIMENTAL
Intervention: Combined intervention group (weight loss and reduced sodium intake)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 222
Study: 10920087

Group type: EXPERIMENTAL
Intervention: Gonal‐F (recombinant human FSH)
Number of subjects: 496

Group type: COMPARATOR
Intervention: Metrodin HP (highly purified urinary human FSH)
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Gonal‐F
Number of subjects: 496

Group type: COMPARATOR
Intervention: Metrodin HP
Number of subjects: 496
Study: 8873535

Group type: EXPERIMENTAL
Intervention: Bump position (head turned to the contralateral side with a rolled towel placed vertically between the scapulas)
Number of subjects: 105

Group type: COMPARATOR
Intervention: No bump position (head facing forward with no towel placed in the back)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Bump position
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: More than three needle passes
Number of subjects: 105
Study: 1524687

Group type: EXPERIMENTAL
Intervention: Triclosan/copolymer pre-brush rinse (0.03% triclosan and 0.125% copolymer)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Matching placebo pre-brush rinse
Number of subjects: 111
Study: 3751955

Group type: EXPERIMENTAL
Intervention: Mixed meals with different types of carbohydrate (potato, white bread, rice, spaghetti, lentils and barley)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Estimated meal glycemic index (GI)
Number of subjects: 6
Study: 31366053

Group type: EXPERIMENTAL
Intervention: 20 g baru almonds (BARU)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 46
Study: 29159578

Group type: EXPERIMENTAL
Intervention: Autism Program Environment Rating Scale (APERS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Professional development program
Number of subjects: 0
Study: 26503312

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (240 mg/kg over 12 h)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24657122

Group type: EXPERIMENTAL
Intervention: MenACWY‐CRM booster dose
Number of subjects: 730

Group type: COMPARATOR
Intervention: MenACWY‐CRM
Number of subjects: 730

Group type: COMPARATOR
Intervention: MenACWY‐D
Number of subjects: 730
Study: 22440819

Group type: EXPERIMENTAL
Intervention: Etanercept (ETA)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Sulfasalazine (SSZ)
Number of subjects: 76
Study: 20576842

Group type: EXPERIMENTAL
Intervention: Plyometric training
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study: 17608635

Group type: EXPERIMENTAL
Intervention: Therapeutic play intervention
Number of subjects: 203

Group type: COMPARATOR
Intervention: Routine information preparation (Control)
Number of subjects: 203
Study: 16182516

Group type: EXPERIMENTAL
Intervention: MacArthur Competence Assessment Tool‐Clinical Research (MacCAT‐CR)
Number of subjects: 1447

Group type: EXPERIMENTAL
Intervention: Negative symptoms
Number of subjects: 1447

Group type: EXPERIMENTAL
Intervention: Working memory
Number of subjects: 1447
Study: 12685416

Group type: EXPERIMENTAL
Intervention: HbAA pregnant women
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: HbAS pregnant women
Number of subjects: 130

Group type: COMPARATOR
Intervention: Non-pregnant control women
Number of subjects: 130
Study: 10072015

Group type: EXPERIMENTAL
Intervention: Adenosine (ADO) infusion (60 microg x kg(‐1) x min(‐1))
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 7735464

Group type: EXPERIMENTAL
Intervention: Codeine detection using high-performance liquid chromatography with fluorescence detection
Number of subjects: 0
Study: 2252185

Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 296

Group type: COMPARATOR
Intervention: Lateral position
Number of subjects: 296
Study: 31391019

Group type: EXPERIMENTAL
Intervention: Incident RPFOA population
Number of subjects: 1295
Study: 27699493

Group type: EXPERIMENTAL
Intervention: S‐1 plus leucovorin and oxaliplatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard S‐1 plus cisplatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 0
Study: 25367150

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 60